Problems and methods in health care economics: is personalized medicine an exception?

被引:0
|
作者
Sickinger, Sabine [1 ]
Payne, Katherine [2 ]
Rogowski, Wolf [1 ]
机构
[1] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Inst Gesundheitsokon & Management Gesundheitswese, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany
[2] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England
关键词
Personalized medicine; Health economic evaluation; Evidence-based decision making; INDIVIDUALIZED CARE; DECISION-MAKING; EMPOWERMENT; INFORMATION;
D O I
10.1007/s00481-013-0266-4
中图分类号
R-052 [医学伦理学];
学科分类号
0101 ; 120402 ;
摘要
Objective For the economic evaluation of medical services, a well-established range of methods is available. The aim of this paper is to determine how and to what extent these methods are applicable to the much-discussed area of personalized medicine and which features may be encountered and how they can be addressed. Methods For this study, an exploratory literature search was conducted. Results In contrast to conventional medicine, personalized medicine might be considered either in terms of physiological differences or in terms of individual preferences of the participants. Depending on the approach, there are different implications for the methodological challenges in health economic evaluations. Improving health care provision regarding physiological differences brings up the problem of parameterization, since evidence is often very weak due to small sample sizes. Value of information analysis can reveal details about the potential benefits of further research. The concept of "expected value of individualized care" provides a very similar approach to the value of information analysis to quantify the potential value of including individual preferences in the health care provision. Welfarism and Extra Welfarism offer different solutions, such as how benefits of biomarker-based information in the sense of "empowerment" can be included in evaluations. Conclusion In general, the methods of economic evaluation are applicable to the field of personalized medicine. However, a number of specific challenges exist. Further research is necessary to solve these problems.
引用
收藏
页码:267 / 275
页数:9
相关论文
共 50 条
  • [1] Probleme und Methoden der Gesundheitsökonomie: Personalisierte Medizin als Sonderfall?Problems and methods in health care economics: is personalized medicine an exception?
    Sabine Sickinger
    Katherine Payne
    Wolf Rogowski
    Ethik in der Medizin, 2013, 25 (3) : 267 - 275
  • [2] Some economics on personalized and predictive medicine
    F. Antoñanzas
    C. A. Juárez-Castelló
    R. Rodríguez-Ibeas
    The European Journal of Health Economics, 2015, 16 : 985 - 994
  • [3] Some economics on personalized and predictive medicine
    Antonanzas, F.
    Juarez-Castello, C. A.
    Rodriguez-Ibeas, R.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2015, 16 (09) : 985 - 994
  • [4] Challenges in the Development and Reimbursement of Personalized Medicine-Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group
    Faulkner, Eric
    Annemans, Leven
    Garrison, Lou
    Helfand, Mark
    Holtorf, Anke-Peggy
    Hornberger, John
    Hughes, Dyfrig
    Li, Tracy
    Malone, Daniel
    Payne, Katherine
    Siebert, Uwe
    Towse, Adrian
    Veenstra, David
    Watkins, John
    VALUE IN HEALTH, 2012, 15 (08) : 1162 - 1171
  • [5] Personalized medicine and access to health care: potential for inequitable access?
    Kelly A McClellan
    Denise Avard
    Jacques Simard
    Bartha M Knoppers
    European Journal of Human Genetics, 2013, 21 : 143 - 147
  • [6] The "We" in the "Me": Solidarity and Health Care in the Era of Personalized Medicine
    Prainsack, Barbara
    SCIENCE TECHNOLOGY & HUMAN VALUES, 2018, 43 (01) : 21 - 44
  • [7] Personalized medicine and access to health care: potential for inequitable access?
    McClellan, Kelly A.
    Ayard, Denise
    Simard, Jacques
    Knoppers, Bartha M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2013, 21 (02) : 143 - 147
  • [8] Personalized medicine and preventive health care: juxtaposing health policy and clinical practice
    Gjodsbol, Iben Mundbjerg
    Winkel, Bo Gregers
    Bundgaard, Henning
    CRITICAL PUBLIC HEALTH, 2021, 31 (03) : 327 - 337
  • [9] Transforming big data into computational models for personalized medicine and health care
    Soroushmehr, S. M. Reza
    Najarian, Kayvan
    DIALOGUES IN CLINICAL NEUROSCIENCE, 2016, 18 (03) : 339 - 343
  • [10] Personalized medicine in psychiatry: problems and promises
    Ozomaro, Uzoezi
    Wahlestedt, Claes
    Nemeroff, Charles B.
    BMC MEDICINE, 2013, 11